Hnp Capital LLC Amgen Inc Transaction History

Hnp Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $8.4 Million - $9.29 Million	38,298 New	38,298 $9.26 Million
Q2 2020 Jul 06, 2020	SELL	$197.81 - $242.74 $8.54 Million - $10.5 Million	-43,177 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $7.87 Million - $10.4 Million	43,177 New	43,177 $8.75 Million
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $202,076 - $259,737	-1,068 Closed	0 $0
Q3 2019 Oct 04, 2019	SELL	$174.11 - $208.62 $40,567 - $48,608	-233 Reduced 17.91%	1,068 $206,000
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $11,168 - $13,092	-67 Reduced 4.9%	1,301 $240,000
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $23,513 - $26,504	-130 Reduced 8.68%	1,368 $260,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $267,243 - $311,958	1,498 New	1,498 $291,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Hnp Capital LLC with notifications on news.